TLIS - Talis Biomedical net loss of $28.65M revenue of $0.86M misses by $0.47M March, 15 2022 04:15 PM Talis Biomedical Corporation Talis Biomedical press release (NASDAQ:TLIS): Q4 Net loss of $28.65M. Revenue of $0.86M (+273.9% Y/Y) misses by $0.47M. For further details see: Talis Biomedical net loss of $28.65M, revenue of $0.86M misses by $0.47M